SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-20-000774
Accepted
2020-04-17 00:15:20
Documents
1
Effectiveness Date
2020-04-16
Registration Form
F-3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 592
  Complete submission text file 9999999995-20-000774.txt   1892
Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018
Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702
Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: EFFECT | Act: 33 | File No.: 333-237389 | Film No.: 20797593
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences